Cargando…

1159. Echinocandins Dosing in Obese Patients: A Systematic Review

BACKGROUND: Echinocandins are a milestone in antifungal chemotherapy given their fungicidal properties with improved toxicity profiles compared to other antifungal agents. Echinocandins are used in the empiric treatment of invasive candidiasis and aspergillosis in critically ill, neutropenic, and tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alsowaida, Yazed S, Pharm, B S, Almulhim, Abdulaziz S, Kalbasi, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777232/ http://dx.doi.org/10.1093/ofid/ofaa439.1345

Ejemplares similares

1326. Vancomycin Area Under the Concentration-Time Curve (AUC) Estimation Using a Bayesian Approach Versus First-Order Pharmacokinetic Equations: A Pilot Study
por: Pearson, Jeffrey, et al.
Publicado: (2020)

Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
por: Almulhim, Abdulaziz S., et al.
Publicado: (2020)

43. A Pharmacoepidemiologic Evaluation of Echinocandin Use
por: Jo, Jinhee, et al.
Publicado: (2020)

1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial
por: Bradley, John S, et al.
Publicado: (2021)

1159. Influenza Symptoms in Vaccinated Healthcare Workers in an H3N2-Dominant Season
por: Bartlett, Allison, et al.
Publicado: (2018)

P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA
por: Zanwar, S., et al.
Publicado: (2022)

P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP
por: Al-Sarayfi, Diana, et al.
Publicado: (2023)

1159. A Phase 2 Drug-Vaccine Interaction Study of AV7909 and Ciprofloxacin or Doxycycline on Antibiotic Pharmacokinetics
por: Akintunde, Gideon, et al.
Publicado: (2023)

157. A Multicenter, Mixed-Method Evaluation of Delayed Hospital Discharge in Patients with Invasive Candidiasis Receiving Echinocandins
por: Jo, Jinhee, et al.
Publicado: (2021)

Echinocandin-resistant Candida tropicalis Bloodstream Infections
por: Sfeir, Maroun, et al.
Publicado: (2017)

146 Review of Empiric Echinocandin Therapy for Candidemia
por: Amado, Cristina, et al.
Publicado: (2014)

372. Attributable Mortality of Candidemia After Introduction of Echinocandins
por: Cornely, Florian, et al.
Publicado: (2018)

2886. The Clinical Implications of High Echinocandin Persistence of a Major Fungal Pathogen and Development of a Rapid and Convenient Approach to Determine Echinocandin Persistence
por: Arastehfar, Amir, et al.
Publicado: (2023)

1159. Multidisciplinary Leadership Rounds Are Associated with Decreased Urinary Catheter and Central Venous Catheter Device Utilization at a Tertiary Care, Academic Hospital
por: Bowling, Jason, et al.
Publicado: (2019)

733. Ibrexafungerp Demonstrates Potent and Consistent In Vitro Activity Against >400 Global Candida auris Isolates, Including isolates with Elevated MIC’s to Echinocandins
por: Borroto-Esoda, Katyna, et al.
Publicado: (2020)

883. Evaluation of Post-operative Antibiotic Prophylaxis in Patients Undergoing Urologic Procedures
por: Elmarakbi, Mohamed, et al.
Publicado: (2020)

Pharmacogn. Mag. has its new Impact Factor – 1.159
por: Ahmed, KK Mueen
Publicado: (2012)

Impact of echinocandins as first-choice therapy in cardiothoracic high-risk patients with candidemia
por: Langebartels, G, et al.
Publicado: (2013)

In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris
por: Badalii, Hamid
Publicado: (2017)

2116. Comparative Effectiveness of Amphotericin B, Azoles, and Echinocandins in the Treatment of Candidemia and Invasive Candidiasis: A Systematic Review and Network Meta-Analysis
por: Demir, Koray K, et al.
Publicado: (2019)

381. Morphologic Changes Associated With Echinocandin Tolerance Enhance Immunoevasion of Candida glabrata
por: Hu, Chenlin, et al.
Publicado: (2018)

Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model
por: Zhao, Yanan, et al.
Publicado: (2017)

Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2023)

Review on Current Status of Echinocandins Use
por: Mroczyńska, Martyna, et al.
Publicado: (2020)

2804. Azole versus echinocandin combination therapy for the treatment of invasive mucormycosis: A case series
por: Shah, Meera, et al.
Publicado: (2023)

The in vitro Activity of Echinocandins Against Clinical Trichophyton rubrum Isolates and Review of the Susceptibility of T. rubrum to Echinocandins Worldwide
por: Su, Huilin, et al.
Publicado: (2023)

Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007)

Fungal echinocandin resistance
por: Walker, Louise A., et al.
Publicado: (2010)

Fungal echinocandin resistance
por: Munro, Carol A
Publicado: (2010)

Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus: A Systematic Review and Meta-Analysis
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2022)

Outcomes Comparing Initial Short vs Long Course Echinocandin Therapy in Patients with Candidemia Caused by Fluconazole Susceptible Strains
por: Small-Saunders, Jennifer L, et al.
Publicado: (2017)

Genome Sequence of an Enterobacter helveticus Strain, 1159/04 (LMG 23733), Isolated from Fruit Powder
por: Grim, Christopher J., et al.
Publicado: (2013)

CRISPR/Cas9 mediated gene editing in non-model nematode Panagrolaimus sp. PS1159
por: Hellekes, Viktoria, et al.
Publicado: (2023)

The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Candida glabrata Colonization Mouse Model
por: Healey, Kelley, et al.
Publicado: (2017)

2400. Activity of a Long-Acting Echinocandin, Rezafungin, Tested Against Invasive Fungal Isolates Collected Worldwide
por: Pfaller, Michael A, et al.
Publicado: (2018)

752. Decreased Echinocandin Resistance among Candida glabrata over an Eleven-Year Period at a University Hospital
por: Raabe, Nathan, et al.
Publicado: (2022)

“Illuminating” Echinocandins’ Mechanism of Action
por: Loh, Boon Shing, et al.
Publicado: (2020)

Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta‐analysis
por: Liu, Xiaoqing, et al.
Publicado: (2020)

2117. Fluconazole vs. Echinocandins as Initial Therapy for Candidemia Caused by Fluconazole-Susceptible Species in the Era of Rapid Diagnostic Testing
por: Roshdy, Danya, et al.
Publicado: (2019)

384. Factors Potentiating the Risk of Linezolid-induced Thrombocytopenia in Patients without Haemato-oncologic Diseases: A Case-control Study
por: Thabit, Abrar K, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_addk4pqn9vcj568rthognmpn5n